Sign in
4

Changes in Ownership

SpyGlass Pharma, Inc. Filed Acc 0001427569-26-000008

Options or other derivatives

  • Chief Financial Officer acquired 17,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Viret Jean-Frederic · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-05 Grant or award : show line 1 in the form Stock Option (right to buy) +17,500 17,500 D
Loading xslF345X05/form4-02092026_090235.xml…